← back to search

Quaid Morris

Wayne State University · US
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer Genomics and Diagnostics, RNA Research and Splicing, RNA modifications and cancer, and Radiomics and Machine Learning in Medical Imaging.
h-index
118
citations
102,746
works
641
NIH funding
primary concept
Biology
email

Recent publications

A resource of RNA-binding protein motifs across eukaryotes reveals evolutionary dynamics and gene-regulatory function
Nature Biotechnology 2025cited by 11position: lastdoi
Integrative spatial omics reveals distinct tumor-promoting multicellular niches and immunosuppressive mechanisms in Black American and White American patients with TNBC
Nature Communications 2025cited by 11position: middledoi
CisBP-RNA: a web resource for eukaryotic RNA-binding proteins and their motifs
Nucleic Acids Research 2025cited by 9position: middledoi
Deep-Learning Model for Tumor-Type Prediction Using Targeted Clinical Genomic Sequencing Data
Cancer Discovery 2024cited by 25position: lastdoi
Orthrus: Towards Evolutionary and Functional RNA Foundation Models
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 16position: middledoi
Crowd-sourced benchmarking of single-sample tumor subclonal reconstruction
Nature Biotechnology 2024cited by 9position: middledoi
RNA-binding proteins that lack canonical RNA-binding domains are rarely sequence-specific
Scientific Reports 2023cited by 54position: middledoi
SON is an essential m6A target for hematopoietic stem cell fate
Cell stem cell 2023cited by 17position: middledoi
Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions
Cancer Research 2022cited by 12position: middledoi
Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
Nature Communications 2022cited by 2position: middledoi
Author Correction: Inferring structural variant cancer cell fraction
Nature Communications 2022cited by 0position: middledoi
Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
Nature Communications 2022cited by 0position: middledoi
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes
Cell 2021cited by 550position: middledoi
A practical guide to cancer subclonal reconstruction from DNA sequencing
Nature Methods 2021cited by 198position: middledoi
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
Nature Communications 2020cited by 235position: middledoi
Relapse-Fated Latent Diagnosis Subclones in Acute B Lineage Leukemia Are Drug Tolerant and Possess Distinct Metabolic Programs
Cancer Discovery 2020cited by 100position: middledoi
A community effort to create standards for evaluating tumor subclonal reconstruction
Nature Biotechnology 2020cited by 97position: middledoi
Inferring structural variant cancer cell fraction
Nature Communications 2020cited by 56position: middledoi
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
Nature Communications 2020cited by 50position: middledoi
Characterizing Genetic Intra-Tumor Heterogeneity Across 2,658 Human Cancer Genomes
SSRN Electronic Journal 2020cited by 10position: middledoi
GeneMANIA update 2018
Nucleic Acids Research 2018cited by 1,417position: lastdoi
High-Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated Granules and Bodies
Molecular Cell 2018cited by 812position: middledoi
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes
bioRxiv (Cold Spring Harbor Laboratory) 2018cited by 108position: middledoi
Neutral tumor evolution?
Nature Genetics 2018cited by 76position: middledoi
Loss of miR-204 expression is a key event in melanoma
Molecular Cancer 2018cited by 42position: middledoi
Abstract 3000: Pervasive intra-tumour heterogeneity and subclonal selection across cancer types
Cancer Research 2018cited by 9position: middledoi
Abstract 218: The evolutionary history of 2,658 cancers
Cancer Research 2018cited by 1position: middledoi
The evolutionary history of 2,658 cancers
bioRxiv (Cold Spring Harbor Laboratory) 2017cited by 58position: middledoi
An RRM–ZnF RNA recognition module targets RBM10 to exonic sequences to promote exon exclusion
Nucleic Acids Research 2017cited by 45position: middledoi
Neutral tumor evolution?
bioRxiv (Cold Spring Harbor Laboratory) 2017cited by 3position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Timothy R. Hughes · University of Toronto6 papers (2013–2025)Debashish Ray · University of Toronto5 papers (2015–2025)Cyrus L. Tam · Memorial Sloan Kettering Cancer Center4 papers (2023–2025) · 3 papers (2023–2025)Maxime Tarabichi · Université Libre de Bruxelles3 papers (2017–2021)Matthew T. Weirauch · Cincinnati Children's Hospital Medical Center3 papers (2013–2025)Peter Van Loo · The University of Texas MD Anderson Cancer Center3 papers (2017–2021)David C. Wedge · University of Manchester3 papers (2017–2021)Mihai Albu · University of Toronto3 papers (2023–2025)Alexander Sasse · Technical University of Munich2 papers (2025–2025)Paul T. Spellman · University of California System2 papers (2017–2018)Amit G. Deshwar · University of Toronto2 papers (2013–2021)Leo J. Lee · University of Toronto2 papers (2014–2024)Florian Markowetz · University of Cambridge2 papers (2017–2018)Khalid Zuberi · University of Toronto2 papers (2013–2018)Iñigo Martincorena · European Bioinformatics Institute2 papers (2017–2018)Brendan J. Frey · University of Toronto2 papers (2014–2024)Moritz Gerstung · Open Targets2 papers (2017–2018)Paul C. Boutros · University of Virginia2 papers (2013–2021)Ole Christian Lingjærde · University of Oslo2 papers (2017–2018)